Govt constitutes panel to frame new law for drugs, cosmetics, medical devices

NEW DELHI: The government has constituted an eight-member panel for framing a new law for drugs, cosmetics and medical devices.

The panel is being headed by Drugs Controller General of India (DCGI) Dr V G Somani.

“The government has decided to constitute a committee for framing/preparation of the New Drugs, Cosmetics and Medical Devices Bill so that the New Drugs, Cosmetics and Medical Devices Act can be framed,” a health ministry order issued recently said.

The Drugs and Cosmetics Act, 1940, regulates the import, manufacture, distribution and sale of drugs, cosmetics and medical devices. This Act is amended from time to time. The last amendment in the Act was made in 2008.

On the terms of reference of the committee, the order said, “The committee shall undertake pre-legislative consultations and examine the present Act, previously framed Drugs and Cosmetics Bills and submit a draft documents for a de-novo Drugs, Cosmetics and Medical Devices Bill by November 30, 2021.”

Related Posts

  • Pharma
  • August 1, 2025
  • 15 views
Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

The headline equity benchmarks ended with significant losses today, as investors turned cautious following the U.S. imposition of steep tariffs on multiple trade partners and the reaffirmation of a 25%…

  • Pharma
  • August 1, 2025
  • 49 views
Karnataka issues order to merge Ayush drug dept with State FDA

Karnataka government has issued order on the merger of the Ayush (Ayurveda, Unani, Siddha Homeopathy) Drug Licensing Authority / Drug Enforcement Division & Drug testing Laboratories with State Food and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Karnataka issues order to merge Ayush drug dept with State FDA

Karnataka issues order to merge Ayush drug dept with State FDA

Orchid Pharma buyback rights to novel antibiotic; stock up 5%

Orchid Pharma buyback rights to novel antibiotic; stock up 5%

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram